## Abstract In the mid‐1980s, the treatment of Parkinson's disease was quite exclusively centered on dopatherapy and was focusing on dopamine systems and motor symptoms. A few dopamine agonists and a monoamine oxidase B inhibitor (selegiline) were used as adjuncts in advanced Parkinson's disease. I
✦ LIBER ✦
Astrocytes and therapeutics for Parkinson’s disease
✍ Scribed by Phillip M. Rappold; Kim Tieu
- Book ID
- 108231604
- Publisher
- Springer-Verlag
- Year
- 2010
- Tongue
- English
- Weight
- 439 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1933-7213
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Milestones in Parkinson's disease therap
✍
Olivier Rascol; Andres Lozano; Matthew Stern; Werner Poewe
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
English
⚖ 228 KB
Cell Therapeutics in Parkinson’s Disease
✍
Olle Lindvall; Anders Björklund
📂
Article
📅
2011
🏛
Springer-Verlag
🌐
English
⚖ 444 KB
Therapeutic directions for Parkinson's d
✍
Ira Shoulson
📂
Article
📅
2010
🏛
John Wiley and Sons
🌐
English
⚖ 51 KB
## Abstract The focus on disease‐modifying treatments and cures for Parkinson's disease (PD) has raised expectations for quantum leaps and overshadowed incremental gains that have been slowly achieved. Large multi‐center clinical trials such as DATATOP and PRECEPT keep on generating new knowledge t
Cell-based Therapeutic Strategies for Pa
✍
C. Grothe
📂
Article
📅
2006
🏛
John Wiley and Sons
🌐
German
⚖ 60 KB
👁 1 views
Cell-based Therapeutic Strategies for Pa
✍
F. Tiemann
📂
Article
📅
2006
🏛
John Wiley and Sons
🌐
German
⚖ 31 KB
👁 1 views
Parkinson’s disease: oxidative stress an
✍
Sankar Surendran; Srinivasagam Rajasankar
📂
Article
📅
2010
🏛
Springer Milan
🌐
English
⚖ 273 KB